By Ann Dieleman (April 13, 2022)There are times when collaboration seems like an uphill battle, especially in a highly competitive industry where billions of lives (and dollars) are at stake. But this was precisely the situation pharmaceutical companies found themselves in during the race to develop the COVID-19 vaccine.
Read the full story here >>>#PressRelease